AGENT IDE presented at #TCT2023 . In patients with in-stent restenosis, the Agent drug-coated balloon reduced the risk of TLF at 1 year versus POBA, with a NNT of 9. A somewhat inexplicable applause broke out in the room given the obviousness of the result (at least in Europe).